| This week's sponsor is CMIC Group. | | | |
Today's Rundown Gilead taps Nurix's protein degradation tech in $45M cancer pact Distrust is frustrating U.K. NHS-industry cooperation: report Schrödinger hires ex-Eisai, Merck staff for push into clinic Canaan-backed Comet uncloaks with $28.5M and biopharma vet De Graaf at the helm Qiagen launches one-stop antimicrobial resistance database alongside CDC commitment Kymera rolls out new animal data on its lead protein-degradation drug to treat lymphoma Featured Story | | | Wednesday, June 19, 2019 Gilead is enlisting Nurix to create new cancer medicines that break down disease-causing proteins. The Big Pharma is handing over $45 million upfront in a deal that could reach $2.3 billion in value if all milestones are met and royalties realized. |
|
|
| This week's sponsor is Covance. | | | |
Top Stories Wednesday, June 19, 2019 Britain’s NHS and pharma industry are failing to collaborate effectively, according to a report involving people on both sides. The report cites distrust among the barriers that are limiting the number of effective cross-sector collaborations. Wednesday, June 19, 2019 Schrödinger has hired researchers from Eisai and Merck to support the progress of its wholly owned assets toward the clinic. The news comes weeks after Schrödinger pulled in more cash to fund its evolution into a biotech with an internal pipeline. Wednesday, June 19, 2019 Comet Therapeutics unveiled itself with $28.5 million in series A financing and biopharma veteran David De Graaf, Ph.D., as its CEO. The capital will carry Comet through 2021, when it plans to move its first program into the clinic. Tuesday, June 18, 2019 In the face of growing international concerns over antimicrobial resistance, Qiagen has launched a one-stop shop that compiles publicly available genomic data, scientific literature and phenotypic information on potential superbugs. Wednesday, June 19, 2019 Kymera is presenting new preclinical data on the lead protein-degradation drug in its pipeline, KYM-001, which it’s developing to treat a particularly aggressive subset of B-cell lymphoma. In mice, the drug promoted tumor regression, both on its own and in combination with BTK inhibitor Imbruvica. | This week's sponsor is Cryoport. | | | |
Resources Sponsored by: Titian Software This Essential Guide to Managing Laboratory Samples is a three-part piece exploring common problems experienced in the management of samples and how, for any scale of operation, significant efficiency and accuracy benefits can be gained using dedicated sample management software. Sponsored by: Elemental Machines How can the Internet of Things (IoT) enable you to meet GxP? Sponsored by: Veradigm Patients living with diabetes deserve better – Real-World Evidence for effecting/realizing change in the management of type 2 diabetes and cardiovascular/renal comorbidities. Sponsored by: OCT Clinical Trials | June 20, 2019 | 2pm EDT / 11am PDT Fast and cost-efficient patient-enrollment,100% success strategy for obtaining a CTA, unified market authorization across the EEU countries. Find out the key compelling reasons to conduct studies in Russia. Sponsored by: AlphaSense What is agile competitive intelligence, and how can it help take market research to the next level? Sponsored by: Reprints Desk, Inc. Get 5 quick tips for faster research and better results! Sponsored by: Blue Latitude Health In this publication, Blue Latitude Health maps the journey of stakeholders impacted by the rise of precision medicine today. Download the report. Sponsored by: Patheon, by Thermo Fisher Scientific Increase Safety & Flexibility with Flow Chemistry Sponsored by: Veeva IONIS shares best practices for implementing an end-to-end RIM solution in this on-demand webinar. Watch now. Sponsored by: WCG Increasingly complex clinical trials place a tremendous burden on study sites, exacerbating already-troubling recruitment and enrollment issues. Overwhelmed, many sites may not be up to the task or have the appropriate infrastructure, creating costly delays that keep new therapies from patients. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. Medical Sensors Design Conference June 25, 2019 | McEnery Convention Center | San Jose, CA Sensors Expo & Conference June 25-27, 2019 | McEnery Convention Center | San Jose, CA Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register and start preparing Today! | 